Medical Foam Market worth $43.3 billion by 2028 | Key players Dow Chemical Company (US), Sekisui Chemical Co., Ltd. (Japan), Huntsman Corporation (US).

According to recent market research the "Medical Foam Market by Form (Flexible, Rigid, Spray), Material (Polymers, Latex, Metals), Application (Bedding & Cushioning, Medical Packaging, Medical Devices & Components, Prosthetics & Wound Care), and Region - Global Forecast to 2028", size is projected to grow from USD 33.0 billion in 2023 and reach USD 43.3 billion by 2028, at a CAGR of 5.6% from 2023 to 2028. The expansion of this market can be credited to several factors, including the upward trend in the elderly population, the surge in worldwide healthcare spending, the advancement of implantable devices, and consumers transitioning from conventional to more sophisticated wound care solutions.

Browse 377 market data Tables and 51 Figures spread through 307 Pages and in-depth TOC on "Medical Foam Market - Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/medical-foam-market-176803616.html

Flexible foam stands out as the most extensively utilized due to its softness, flexibility, and durability. The rise in demand for this foam type is linked to its more economical nature compared to rigid and spray foam options. Moreover, its considerable use in bedding and cushioning, packaging medical devices, and wound care dressing has significantly propelled market expansion. The prevalence of flexible foam in these applications is due to its attributes, including softness, moisture resistance, and superior impact and mechanical properties.

In terms of material, the polymer segment is anticipated to hold the leading position in the medical foam industry. This segment's growth is credited to its widespread availability, ease of production, and cost-effectiveness. Polymer foams exhibit characteristics such as lightweight structure, heat retention, sound absorption, biocompatibility, and exceptional cushioning. Key polymer foam varieties utilized in medical contexts encompass polyurethane foam, polystyrene foam, polyolefin foam, among others.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=176803616

In the forecast period, the most significant surge in the global medical foam market is projected to occur within medical packaging segment. Safeguarding the integrity and hygiene of medical products is paramount, making the packaging of medical devices, tools, and equipment very crucial. This encompasses the packaging of implants, medical tools, equipment, and in-vitro diagnostic devices (IVDs). The selection of packaging material varies according to the application and relies on the product's intended function. For instance, plastics or metals find use in implant packaging.

In 2022, the Asia Pacific region held the dominant share in the global medical foam industry. Forecasts suggest that this region will experience the highest Compound Annual Growth Rate (CAGR) between 2023 and 2028. The Asia Pacific market for medical foam is emerging as a lucrative sector due to demographic shifts, rising healthcare expenditure, industrial advancements, and improving economic circumstances. With approximately 60% of the world's population residing in this region, there is extensive utilization of medical packaging, prosthetics, and medical devices.

Some of the leading manufacturers of medical foam profiled in this report are The Dow Chemical Company (US), Sekisui Chemical Co., Ltd. (Japan), Huntsman Corporation (US), Trelleborg AB (Sweden), BASF SE (Germany), Recticel NV (Belgium), INOAC Corporation (Japan), UFP Technologies, Inc. (US), FXI Holdings, Inc. (US), Armacell International SA (Germany), Rogers Corporation (US), Freudenberg Group (Germany), and Molnlycke Health Care (Sweden).

For more Details Speak to Our Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=176803616

The Dow Chemical Company stands at the forefront of integrated science and technology, crafting and delivering essential raw materials for various consumer goods and services. With a presence in packaging & specialty plastics, industrial intermediates & infrastructure, and performance materials & coatings, Dow serves an extensive range of industries-from automotive and electronics to healthcare and construction. Their polyurethanes and polystyrene foams cater to diverse needs, spanning energy-efficient buildings, medical instruments, consumer comfort in furniture and footwear, and even specialized foam applications. Dow actively engages with customers, particularly in medical applications, to ensure optimal use and potential assessments, boasting a global footprint with 109 manufacturing sites across 31 countries.

Sekisui Chemical Co., Ltd. advances housing, urban infrastructure, and the production of environmental solutions alongside cutting-edge, high-performance plastics on a global scale. Operating through distinct segments-housing, urban infrastructure & environmental products (UIEP), and high-performance plastics (HPP)-the company offers a diverse range of electronic components such as LCD fine particles, photosensitive materials, semiconductor materials, optical adhesive tapes & films, double-faced tapes, ITO films, polyolefin foams, and LED materials within the HPP realm. Moreover, this segment extends its portfolio to include resin materials medical products from vacuum blood collection tubes to in-vitro diagnostics, amino acids, pharmaceutical products, intermediates, medical-related items, research services, adhesives, packaging tapes, and plastic containers. Sekisui Chemical conducts its business through two primary grades-Softlon and Volara-crafted via advanced irradiated cross-linking technology, delivering nearly 100% closed-cell foam solutions. These foam grades find extensive applications across automotive interiors, medical device packaging, information technology, construction underlayment, insulation, air conditioning piping, packaging materials, industrial insulation, sports and leisure products, consumer goods, and various medical care applications.

Contact:

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Press Release: https://www.marketsandmarkets.com/PressReleases/medical-foam.asp
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/medical-foam-market.asp

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.